| Document Date: 2012-08-16 05:31:52
Open Document File Size: 127,91 KBShare Result on Facebook
City Oxford / / Country Thailand / Kenya / Belgium / United Kingdom / / / Event Product Issues / / IndustryTerm health-care infrastructure / universal health services / pharmaceutical industry / law enforcement priorities / public health-care infrastructure / counterfeit products / harmful products / law enforcement / retail pharmaceutical outlets / / Organization Medicines Transparency Alliance / civil society / World Health Organization / Oxfam / European Union / Thai government / / Person Brook Baker / Jonathan Berger / Charles Clift / Philippa Saunders / Rohit Malpani / Katrien Vervoort / Wilbert Bannenberg / Tom Greenwood / Mark Fried / Sangeeta Shashikant / Alain Prat / Sophie Bloemen / Jean-Michel Caudron / Sanya Reid Smith / Matt Price / Jennifer Brant / Peter Maybarduk / Sergio Andrade Nishioka / Stephanie Burgos / / Product quality / / URL www.oxfam.org.hk / www.oxfamsol.be / www.oxfamfrance.org / www.intermonoxfam.org / www.oxfam.qc.ca / www.oxfam.org.uk / www.oxfam.ca / www.oxfam.org.au / www.oxfamireland.org / www.oxfammexico.org / www.oxfam.jp / www.oxfamnovib.nl / www.oxfam.de / www.oxfamindia.org / www.oxfamitalia.org / www.oxfam.org.nz / www.oxfam.org / www.oxfamamerica.org / /
SocialTag |
Eye on the Ball: Medicine regulation – not IP enforcement – can best deliver quality medicines